Neurobiology of relapse to alcohol in rats

Pharmacology and Therapeutics

Volumn 94, Issue 1-2, 2002, Pages 137-156

  Le A D ^a   Shaham, Y ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Alcohol deprivation effect; Conditioned drug cues; Extinction; Reinstatement; Review; Stress

Indexed keywords

ACAMPROSATE; ALCOHOL; BEMESETRON; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; ENADOLINE; FLUOXETINE; KAPPA OPIATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; NALTREXONE; NERAMEXANE; NOCICEPTIN; ONDANSETRON; OPIATE ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TROPISETRON;

ALCOHOL ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL BEHAVIOR; ASSOCIATION; DRUG SELF ADMINISTRATION; HUMAN; NERVE CELL NETWORK; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; RELAPSE; REVIEW; STRESS; ANIMAL; BRAIN; DRINKING BEHAVIOR; DRUG EFFECT; INSTRUMENTAL CONDITIONING; MENTAL STRESS; METABOLISM; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE;

ALCOHOL DRINKING; ALCOHOLISM; ANIMAL; BEHAVIOR, ANIMAL; BRAIN; CONDITIONING, OPERANT; CUES; ETHANOL; RATS; RECURRENCE; SELF ADMINISTRATION; STRESS, PSYCHOLOGICAL; SUPPORT, NON-U.S. GOV'T; ANIMALS;

EID: 0036016259     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(02)00200-0     Document Type: Review

References (204)

1. Development of short-lasting alcohol deprivation effect in sardinian alcohol-preferring rats
2. Cocaine- but not food-seeking behavior is reinstated by stress after extinction
3. Alteration of ethanol self-administration by naltrexone
4. The role of physical dependence in animal models of human alcoholism
5. Serotonin uptake inhibitors: Effects on motivated consummatory behaviors
6. Effects of inescapable shock and shock-produced conflict on self-selection of alcohol in rats
7. Naloxone retards the expression of a genetic predisposition toward alcohol drinking
8. Animal models of alcohol withdrawal
9. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: Implications for the treatment of CNS disorders
10. Behavioral pharmacology of cocaine and the determinants of abuse liability
11. Addiction, dopamine, and the molecular mechanisms of memory
12. Ethanol-reinforced behaviour in the rat: Effects of naltrexone
13. The role of drug-paired stimuli in extinction and reinstatement of ethanol-seeking behaviour in the rat
14. Reinstatement of ethanol seeking in rats: Behavioral analysis
15. Current advances and trends in the treatment of depression
16. Relationship of stress to brain and serotonin and 5-hydroxyindoleacetic acid
17. A homotaurine derivative reduces the voluntary intake of ethanol by rats: Are cerebral GABA receptors involved?
18. Sources of relapse after extinction in Pavlovian and instrumental learning
19. Stress, vulnerability and adult alcohol relapse
20. Stress reinstates nicotine seeking but not sucrose solution seeking in rats
21. Effects of voluntary short-term abstinence from alcohol on subsequent drinking patterns of college students
22. Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release
23. Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: A centrally active corticotropin-releasing factor1 receptor antagonist
24. Resumption of ethanol-seeking behaviour in rats
25. United Kingdom Multicentre Acamprosate Study (UKMAS): A 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol
26. Ethanol preloads increase ethanol preference under concurrent random-ratio schedules in social drinkers
27. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats
28. 1 antagonists
29. Multiple effects of ethanol on the hypothalamic-pituitary gonadal axis in the male
30. Stress and alcohol use: Moderating effects of gender, coping and alcohol expectancies
31. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction
32. A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior
33. Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior
34. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration
35. Reinstatement of cocaine-reinforced responding in the rat
36. Drugs abused by humans preferentially increase synaptic dopamine transmission concentration in the mesolimbic system of freely moving rats
37. Physiological and behavioral responses to corticotropin-releasing factor: Is CRF a mediator of anxiety or stress responses?
38. Response-dependent versus response-independent presentation of cocaine: Differences in the lethal effects of the drug
39. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking
40. Stress reinstates cocaine-seeking behavior after prolonged extinction and drug-free periods
41. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats
42. Stress-induced relapse to drug seeking in the rat: Role of the bed nucleus of the stria terminalis and amygdala
43. Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems
44. Second-order schedules of drug reinforcement in rats and monkeys: Measurement of reinforcing efficacy and drug-seeking behaviour
45. MDL 72222, a selective 5-HT3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats
46. Involvement of corticosterone in the modulation of ethanol consumption in the rat
47. Metyrapone-induced suppression of corticosterone synthesis reduces ethanol consumption in high-preferring rats
48. Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists
49. Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone
50. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum
51. Failure to find postshock increases in ethanol preference
52. Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference
53. Importance of delta opiate receptors in maintaining high alcohol drinking
54. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis
55. Voluntary ethanol consumption in rats: An examination of blood/brain ethanol levels and behavior
56. A neuroendocrine role in cocaine reinforcement
57. Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens
58. Oral self administration of ethanol in free feeding rats
59. Role of serotonin and catecholaines in brain in the feeding suppressant effect of fluoxetine
60. Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of relapse
61. Incubation of cocaine craving over weeks of cocaine withdrawal in rats
62. Significance of adrenal corticosteroid secretion for the food-induced enhancement of alcohol drinking in the rat
63. Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat
64. Endogenous opioid systems and alcohol addiction
65. Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm
66. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats
67. Effect of drug influencing 5-HT function on ethanol drinking and feeding behavior in rats: Studies using a drinkometer system
68. Involvement of the medial septum in stress-induced relapse to heroin seeking in rats
69. Revitalization of the AA and ANA rat lines: Effects on some line characteristics
70. Effect of the 5-HT1a receptor agonist on the release of 5-HT in dorsal and median raphe-inneverated rat brain regions as measured by in vivo microdialysis
71. Specific decreases in ethanol- but not water-reinforced responding produced by the 5-HT3 antagonist ICS 205-930
72. Alcohol dependence and the priming effect
73. Progressive ratio as a measure of reward strength
74. Commentary on the utility of experimental social and learning models of alcoholism
75. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
76. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats
77. Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation
78. Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure
79. Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats
80. Factors in alcoholic relapse
81. Relapse rates in addiciton programs
82. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking
83. Neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
84. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial
85. Mechanisms of stress: A dynamic overview of hormonal and behavioral homeostasis
86. Predictability, surprise, attention and conditioning
87. Ethanol-associated olfactory stimuli reinstate ethanol-seeking behavior after extinction and modify extracellular dopamine levels in the nucleus accumbens
88. Ethanol anticipation enhances dopamine efflux in the nucleus accumbens of alcohol-preferring (P) but not Wistar rats
89. Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat
90. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid
91. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid
92. Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol consumption in rats
93. Introduction to the symposium "the functional properties of hypothalamus"
94. Neurobiological substrates for the anti-anxiety effects of ethanol
95. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
96. Effects of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys
97. The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference
98. Relapse prevention. An overview of Marlatt's cognitive-behavioral model
99. The effects of selective blockade of delta and mu opiate receptors on alcohol consumption by C57BL/6 mice in a restricted access paradigm
100. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats
101. Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress in rats
102. Median raphe infusions of the 5-HT1a receptor agonist, 8-OH-DPAT, reinstate alcohol seeking in rats
103. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats
104. Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate
105. Clinical perspectives for the study of craving and relapse in animal models
106. Selective breeding for alcohol preference and associated responses
107. Alcohol consumption in free feeding rats: Procedure, genetic and pharmacokinetic factors
108. History of ethanol dependence determines long-term vulnerability to "relapse" induced by stress and ethanol-related cues in rats
109. Craving and relapse to drink
110. The first drink. Psychobiological aspects of craving
111. Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats: Relationship to the discriminative stimulus effects of cocaine
112. Effects of contingent and non-contingent cocaine on drug-seeking behavior measured using a second-order schedule of cocaine reinforcement in rats
113. Models of relapse and relapse prevention: A commentary
114. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats
115. The alcohol deprivation effect in the alcohol-preferring P rat under free-drinking and operant access conditions
116. 3 antagonist, on operant responding for ethanol by alcohol preferring P rats
117. Oral drug self-administration: Drugs as reinforcers
118. The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal
119. Predicting relapse and recovery in alcoholism and addiction: Neuropsychology, personality, and cognitive style
120. The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments
121. Alcohol cue reactivity: Effects of detoxification and extended exposure
122. Failure to find stress of electric shock to increase ethanol intake in rats
123. New developments in the pharmacotherapy of alcohol dependence
124. Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers
125. Fluoxetine attenuates alcohol intake and desire to drink
126. The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions
127. A range of research-based pharmacotherapies for addiction
128. Naltrexone and coping skills therapy for alcohol dependence: A controlled study
129. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum
130. Pathophysiological basis of vulnerability to drug abuse: Interaction between stress, glucocorticoids, and dopaminergic neurons
131. Glucocorticoids as a biological substrate of reward: Physiological and pathophysiological implications
132. Effects of periodic withdrawal on ethanol and saccharin selection in rats
133. Saccharin elation effect
134. Interaction of ethanol and stress: Research with experimental animals - An update
135. Regulation of serotonin (5-HT) release in the lateral septum by forced swimming involves corticotropin releasing factor (CRF)
136. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor
137. Effects of corticotropin-releasing factor on brain serotonergic activity
138. Progressive ratio schedules in drug self-administration studies in rats: A method to evaluate reinforcing efficacy
139. Heroin self-administration in rats under a progressive ratio schedule of reinforcement
140. Self-administration of cocaine on a progressive ratio schedule in rats: Dose-response relationship and effect of haloperidol pretreatment
141. 3 receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats
142. The expression of an alcohol deprivation effect in the high-alcohol-drinking replicate rat lines is dependent on repeated deprivations
143. A critical review of 5-HT brain microdialysis and behavior
144. Interaction between alcohol deprivation and morphine withdrawal in mice
145. Neurobiology of alcohol abuse
146. Oral ethanol self-administration in the rat: Effect of naloxone
147. The role of corticotropin-releasing factor in drug addiction
148. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence
149. CP154,526: A potent and selective non-peptide antagonist of corticotropin releasing factor receptors
150. Self administration of and behavioral dependence on drugs
151. Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior
152. Relapse to drug-seeking: Neural and molecular mechanisms
153. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists
154. 5-HT and alcohol abuse
155. Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence
156. Stress reinstates heroin self-administration behavior in drug-free animals: An effect mimicking heroin, not withdrawal
157. Effects of opioid and dopamine receptor antagonists on relapse induced by stress and reexposure to heroin in rats
158. Relapse to heroin-seeking under opioid maintenance: The effects of opioid withdrawal, heroin priming and stress
159. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats
160. CP-154,526, a selective, non peptide antagonist of the corticotropin-releasing factor type 1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats
161. Stress-induced relapse to heroin and cocaine seeking in rats: A review
162. Time dependent changes in extinction behavior and stress-induced reinstatement of drug seeking during heroin withdrawal
163. The alcohol-deprivation effect in monkeys
164. The alcohol-deprivation effect. Influence of various factors
165. Alcohol-deprivation effect in rats genetically selected for their ethanol preference
166. Compensatory behaviors: Suggestion for a common basis from deficits in hamsters
167. Long and short alcohol deprivation: Effects on AA and P alcohol-preferring rats
168. Increased preference for ethanol in rats following alcohol deprivation
169. Development of an alcohol-deprivation effect in rats
170. Behavioral and physiological changes associated with various durations of alcohol deprivation in rats
171. Pharmacological validation of a new animal model of alcoholism
172. Anti-craving compounds for ethanol: New pharmacological tools to study addictive processes
173. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat
174. Cue reactivity in alcohol abusers: Stimulus specificity and extinction of the responses
175. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area
176. Pathways to relapse: The neurobiology of drug- and stress-induced relapse to drug-taking
177. Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs
178. Drug-induced reinstatement of amphetamine self-administration behaviour in monkeys
179. Factors affecting behavior maintained by response-contingent intravenous infusions of amphetamine in squirrel monkeys
180. Morphine self-administration, food-reinforced and avoidance behaviors in rhesus monkeys
181. Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure
182. Time-dependent changes in cocaine-seeking behavior and dopamine overflow in the amygdala during cocaine withdrawal
183. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin
184. Social stress and ethanol self-administration in rats
185. The influence of control over appetitive and aversive events on alcohol preference in rats
186. Naltrexone in the treatment of alcohol dependence
187. Relapse to cocaine-seeking after hippocampal theta burst stimulation
188. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: Genetic and motivational determinants
189. Control of cocaine-seeking behavior by drug-associated stimuli in rats: Effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens
190. Response to alcohol cues as a function of consumption level
191. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
192. Catecholamine theories of reward: A critical review
193. Neurobiology of addiction
194. Brain dopamine and reward
195. Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats
196. From controlled drug intake to loss of control: The irreversible development of drug addiction in the rat
197. Animal models of addiction: Models for therapeutic strategies?
198. Intravenous self-administration: Response rates, the effects of pharmacological challenges, and drug preference
199. Pharmacotherapy for alcohol dependence